Mass Balance Study of [14C]JAB-21822
NCT05920941
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Mass Balance Study in Healthy Subjects
Interventions
DRUG:
[14C]JAB-21822
Sponsor
Allist Pharmaceuticals, Inc.